Bisphosphonate (olpadronate) retention and its determinants in ...
The BP WBR (WBR = dose BP−amount excreted in urine) was investigated during 5 days of intravenous treatment with olpadronate 8 mg day−1. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18...
|
Skeletal effects and functional outcome with olpadronate in ...
We assessed the effects of oral olpadronate in children with this disorder in a randomised double-blind placebo-controlled trial. ...
http://www.ncbi.nlm.nih.gov/pubmed/15121405...
|
Prevention of osteocyte and osteoblast apoptosis by ...
Etidronate, alendronate, pamidronate, olpadronate, or amino-olpadronate (IG9402, ..... Interestingly, amino-olpadronate (IG9402), a compound that lacks ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=40...
|
Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce ...
Nine patients received both 89Sr and olpadronate at various intervals. Sixteen patients who did not receive any of these treatments were used as historical ...
http://www.ncbi.nlm.nih.gov/pubmed/11914887...
|
Olpadronic acid - Wikipedia, the free encyclopedia
31 Jul 2009 ... Routes ? Olpadronic acid (INN; salt form olpadronate) is a bisphosphonate. Stub icon, This pharmacology-related article is a stub. ...
http://en.wikipedia.org/wiki/Olpadronic_acid...
|
Treatment of osteogenesis imperfecta with the bisphosphonate ...
We treated three boys with severe OI type III and vertebral deformities for 5-7 years with continuous oral administration of the bisphosphonate, olpadronate ...
http://www.ncbi.nlm.nih.gov/pubmed/9365071...
|
Highly potent geminal bisphosphonates. From pamidronate disodium ...
Extending one of the N-methyl groups of olpadronate to a pentyl substituent leads to ibandronate (1k, Roche, Boehringer-Mannheim), which is the most potent
...
http://archive.biomedcentral.com/1860-5397/pubmed/12166945...
|
Intravenous olpadronate restores ovariectomy-affected bone ...
Three months later they were given i.v. doses of 150 (6), 300 (7), or 600 (6) ug /kg 2/wk of olpadronate during 12 weeks or left as OX controls (OXc). ...
http://www.ncbi.nlm.nih.gov/pubmed/8579940...
|
ar-1999-66755 ARJ Paper Report Bisphosphonates prevent osteocyte ...
... treated in vitro with calcitonin or bisphosphonates (etidronate, pamidronate , alendronate, olpadronate or an amino-derivative of olpadronate) for 1 h. ...
http://www.biomedcentral.com/content/download/xml/ar-1999-66...
|
Effects of the bisphosphonate olpadronate in patients with ...
We studied clinical and biochemical responses 5 days and 3 months after administration of the new, potent bisphosphonate, olpadronate, in 28 patients
with ...
http://www.ncbi.nlm.nih.gov/pubmed/9556142...
|
